<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05000424</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00055623</org_study_id>
    <nct_id>NCT05000424</nct_id>
  </id_info>
  <brief_title>Clary Sage Essential Oil &amp; Pregnancy</brief_title>
  <official_title>Clary Sage Essential Oil Inhalation and Third Trimester Quality of Life: A Randomized, Double Blind, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Franklin School of Integrative Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Franklin School of Integrative Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the potential for clary sage essential oil to&#xD;
      support overall health, wellbeing, and quality of life during the third trimester of&#xD;
      pregnancy among otherwise healthy adult women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women will be informed of the opportunity to participate through their care providers,&#xD;
      childbirth educators, or doulas. If they meet inclusion criteria, they will be given a&#xD;
      brochure describing the risks and benefits of the study and the informed consent paperwork.&#xD;
&#xD;
      If they provide consent, they will be randomized to one of two groups: active essential oil&#xD;
      and inert placebo. Both groups will receive a 4-ounce bottle of oil to apply daily during the&#xD;
      third trimester of pregnancy. Those in the placebo group will be given an inert plant oil.&#xD;
      Those in the intervention group will be given the same oil with the addition of clary sage&#xD;
      essential oil.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in salivary estriol levels from pregnancy week 27 to pregnancy week 36.</measure>
    <time_frame>Pregnancy week 27 and 36</time_frame>
    <description>salivary estriol levels are collected via the passive drool method and laboratory analyzed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in quality of life from week 27 to 36 of the pregnancy using the World Health Organization's Quality of Life, Brief-Form Scale (WHOQOL-BREF).</measure>
    <time_frame>Pregnancy week 27 and 36</time_frame>
    <description>This one survey measures overall quality of life through. It contains 26 questions across 4 domains. Questions are scored on a 1-5 likert scale with higher scores indicating higher quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Pregnancy</measure>
    <time_frame>from enrollment to birth, up to 16 weeks</time_frame>
    <description>The total length of the pregnancy (in days) from last menstrual period to birth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of phase 2 of labor</measure>
    <time_frame>from the onset of labor to birth, up to 24 hours</time_frame>
    <description>The total length of phase 2 of labor (in minutes)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Quality of Life</condition>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive a fragrant plant based massage oil with the addition of clary sage essential oil. The massage oil will be massaged into the upper thighs daily for the duration of the third trimester.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants in this group will receive a fragrant plant based massage oil. The massage oil will be massaged into the upper thighs daily for the duration of the third trimester.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clary Sage Massage Oil</intervention_name>
    <description>This massage oil contains clary sage oil. Five drops will be used daily.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inert Massage Oil</intervention_name>
    <description>This massage oil consists entirely of plant based oils. Five drops will be used daily.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 20-39&#xD;
&#xD;
          -  Lives in the United States&#xD;
&#xD;
          -  Pregnant, singleton&#xD;
&#xD;
          -  Low risk&#xD;
&#xD;
          -  Less than 27 weeks gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PCOS diagnosis&#xD;
&#xD;
          -  Uncontrolled Hypertension (i.e. systolic/diastolic blood pressure &gt; 140/90)&#xD;
&#xD;
          -  Gestational Diabetes&#xD;
&#xD;
          -  History of Preeclampsia&#xD;
&#xD;
          -  Preterm labor&#xD;
&#xD;
          -  Incompetent cervix&#xD;
&#xD;
          -  Allergy to salvia sclarea or related plants&#xD;
&#xD;
          -  Known Birth Defects&#xD;
&#xD;
          -  Thyroid Disease diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Franklin Health Research Center</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessie Hawkins, PhD</last_name>
      <phone>615-642-1919</phone>
      <email>j.hawkins@franklinhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clary sage</keyword>
  <keyword>essential oil</keyword>
  <keyword>aromatherapy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

